The expression level of IL-17, which leads to the worsening of RA, was significantly decreased in the LDMJ2 (p = 0.014) and HDMJ2 (p = 0.003) groups when compared with the model group (Figure 6C). This evidence concerns the gene IL17A and rheumatoid arthritis.